(Q53128627)

English

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.

scientific article published in August 2012

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author name string

Aneal Khan

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Thomas Hangartner

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Neal J Weinreb

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

John S Taylor

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Pramod K Mistry

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

27

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

8

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

1839-1848

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Skeletal aspects of Gaucher disease: a review

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone events and evolution of biologic markers in Gaucher disease before and during treatment

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Osteopenia in Gaucher disease develops early in life: response to imiglucerase enzyme therapy in children, adolescents and adults

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Gaucher's Disease. Pathological features

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone fractures after menopause

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone complications in children with Gaucher disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Reducing selection bias in case-control studies from rare disease registries

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Clinically relevant therapeutic endpoints in type I Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Bone density in Type 1 Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Therapeutic goals in the treatment of Gaucher disease.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Nontraumatic necrosis of bone (osteonecrosis).

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

ACTH protects against glucocorticoid-induced osteonecrosis of bone

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Apoptosis in the osteonecrosis of the femoral head

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Marrow fat metabolism is linked to the systemic energy metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Glycosphingolipids and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Evaluation of high density lipoprotein as a circulating biomarker of Gaucher disease activity

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Erythropoiesis, anemia and the bone marrow microenvironment.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.1680

21 January 2018

Identifiers

10.1002/JBMR.1680

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/22692814

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53128627&oldid=2110358786"